-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
CompilationTom Lee
The stock price of Adamis Pharmaceuticals has risen by 31% a few days ago.
Zimhi is a 5 mg/0.
It should be pointed out that this is the third attempt by Adamis after two complete response letters (CRL), and the drug has been approved
Compared with other drugs that require nasal or intramuscular injection, among currently available products, Zimhi can provide patients with the highest level of naloxone throughout the body
It should be noted that Zimhi is only suitable for people who overdose opioids, so it has no effect on people who do not take these drugs.
Reference source: At Last, FDA Signs Off on Adamis' Opioid Overdose Drug